advertisement
Abstract #13417 Published in IGR 8-1
Clinical experience with the double-plate Ahmed glaucoma valve
Al-Aswad LA; Netland PA; Bellows AR; Ajdelsztajn T; Wadhwani RA; Ataher G; Hill RAAmerican Journal of Ophthalmology 2006; 141: 390-391
PURPOSE: To evaluate the clinical efficacy and safety of the double-plate Ahmed Glaucoma Valve. DESIGN: Multicenter, retrospective observational case series. METHODS: We reviewed 50 eyes in 50 patients treated with the double-plate Ahmed Glaucoma Valve with mean follow-up of 11.7 ± 7.9 months. RESULTS: Average intraocular pressure was reduced from 36.0 ± 12.4 mmHg before surgery to 15.8 ± 7.7 mmHg at the most recent follow-up after surgery (P < .001). The number of glaucoma medications was decreased from 3.3 ± 0.8 before surgery to 1.4 ± 1.4 after surgery (P < .001). The percent of success was 76% of eyes at the latest follow-up. Choroidal effusion occurred in four eyes (8%) and did not require surgical treatment in any eye. CONCLUSIONS: Despite a poor prognosis group of patients in this study, the double-plate Ahmed Glaucoma Valve was effective in lowering intraocular pressure with a low incidence of complications associated with hypotony.
Dr. L.A. Al-Aswad, Hamilton Eye Institute, University of Tennessee Health Science Center, Memphis, TN 38163, USA
Classification:
12.8.2 With tube implant or other drainage devices (Part of: 12 Surgical treatment > 12.8 Filtering surgery)
